Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
Joan L. Warren(American Cancer Society), Gerald F. Riley(Unknown), Peter B. Bach(CCC Diagnostics (United States)), Deborah Schrag(Dana-Farber Brigham Cancer Center), Carrie N. Klabunde(National Institutes of Health)
Cited by 1,720
Related Papers
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Diagnosis and Treatment of Metastatic Colorectal Cancer
|JAMA|2021|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k